Table of Contents

1 Study Coverage

• 1.1 Veterinary Antibiotics Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Veterinary Antibiotics Market Size Growth Rate by Product
  • 1.4.2 Tetracyclines
  • 1.4.3 Penicillins
  • 1.4.4 Macrolides
  • 1.4.5 Sulphonamides
  • 1.4.6 Aminoglycosides
  • 1.4.7 Others
• 1.5 Market by End User
  • 1.5.1 Global Veterinary Antibiotics Market Size Growth Rate by End User
  • 1.5.2 Farm Animals
  • 1.5.3 Companion Animals
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Veterinary Antibiotics Market Size
  • 2.1.1 Global Veterinary Antibiotics Revenue 2014-2025
  • 2.1.2 Global Veterinary Antibiotics Sales 2014-2025
• 2.2 Veterinary Antibiotics Growth Rate by Regions
  • 2.2.1 Global Veterinary Antibiotics Sales by Regions
  • 2.2.2 Global Veterinary Antibiotics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Veterinary Antibiotics Sales by Manufacturers
  • 3.1.1 Veterinary Antibiotics Sales by Manufacturers
  • 3.1.2 Veterinary Antibiotics Sales Market Share by Manufacturers
  • 3.1.3 Global Veterinary Antibiotics Market Concentration Ratio (CR5 and HHI)
• 3.2 Veterinary Antibiotics Revenue by Manufacturers
  • 3.2.1 Veterinary Antibiotics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Veterinary Antibiotics Revenue Share by Manufacturers (2014-2019)
• 3.3 Veterinary Antibiotics Price by Manufacturers
• 3.4 Veterinary Antibiotics Manufacturing Base Distribution, Product Types
  • 3.4.1 Veterinary Antibiotics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Veterinary Antibiotics Product Type
  • 3.4.3 Date of International Manufacturers Enter into Veterinary Antibiotics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Veterinary Antibiotics Sales by Product
• 4.2 Global Veterinary Antibiotics Revenue by Product
• 4.3 Veterinary Antibiotics Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Veterinary Antibiotics Breakdown Data by End User

6 North America

• 6.1 North America Veterinary Antibiotics by Countries
  • 6.1.1 North America Veterinary Antibiotics Sales by Countries
  • 6.1.2 North America Veterinary Antibiotics Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Veterinary Antibiotics by Product
• 6.3 North America Veterinary Antibiotics by End User

7 Europe

• 7.1 Europe Veterinary Antibiotics by Countries
  • 7.1.1 Europe Veterinary Antibiotics Sales by Countries
  • 7.1.2 Europe Veterinary Antibiotics Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Veterinary Antibiotics by Product
• 7.3 Europe Veterinary Antibiotics by End User

8 Asia Pacific

• 8.1 Asia Pacific Veterinary Antibiotics by Countries
  • 8.1.1 Asia Pacific Veterinary Antibiotics Sales by Countries
  • 8.1.2 Asia Pacific Veterinary Antibiotics Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Veterinary Antibiotics by Product
• 8.3 Asia Pacific Veterinary Antibiotics by End User

9 Central & South America

• 9.1 Central & South America Veterinary Antibiotics by Countries
  • 9.1.1 Central & South America Veterinary Antibiotics Sales by Countries
  • 9.1.2 Central & South America Veterinary Antibiotics Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Veterinary Antibiotics by Product
• 9.3 Central & South America Veterinary Antibiotics by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Veterinary Antibiotics by Countries
  • 10.1.1 Middle East and Africa Veterinary Antibiotics Sales by Countries
  • 10.1.2 Middle East and Africa Veterinary Antibiotics Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Veterinary Antibiotics by Product
• 10.3 Middle East and Africa Veterinary Antibiotics by End User

11 Company Profiles

• 11.1 Zoetis animal healthcare
  • 11.1.1 Zoetis animal healthcare Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Zoetis animal healthcare Veterinary Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Zoetis animal healthcare Veterinary Antibiotics Products Offered
  • 11.1.5 Zoetis animal healthcare Recent Development
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Merck Veterinary Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Merck Veterinary Antibiotics Products Offered
  • 11.2.5 Merck Recent Development
• 11.3 Merial (Animal Health Division Of Sanofi)
  • 11.3.1 Merial (Animal Health Division Of Sanofi) Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Merial (Animal Health Division Of Sanofi) Veterinary Antibiotics Products Offered
  • 11.3.5 Merial (Animal Health Division Of Sanofi) Recent Development
• 11.4 Elanco
  • 11.4.1 Elanco Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Elanco Veterinary Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Elanco Veterinary Antibiotics Products Offered
  • 11.4.5 Elanco Recent Development
• 11.5 Bayer healthcare
  • 11.5.1 Bayer healthcare Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Bayer healthcare Veterinary Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Bayer healthcare Veterinary Antibiotics Products Offered
  • 11.5.5 Bayer healthcare Recent Development
• 11.6 Ceva Animal Health, Inc.
  • 11.6.1 Ceva Animal Health, Inc. Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Ceva Animal Health, Inc. Veterinary Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Ceva Animal Health, Inc. Veterinary Antibiotics Products Offered
  • 11.6.5 Ceva Animal Health, Inc. Recent Development
• 11.7 Virbac
  • 11.7.1 Virbac Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Virbac Veterinary Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Virbac Veterinary Antibiotics Products Offered
  • 11.7.5 Virbac Recent Development
• 11.8 Boehringer Ingelheim
  • 11.8.1 Boehringer Ingelheim Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Boehringer Ingelheim Veterinary Antibiotics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Boehringer Ingelheim Veterinary Antibiotics Products Offered
  • 11.8.5 Boehringer Ingelheim Recent Development

12 Future Forecast

• 12.1 Veterinary Antibiotics Market Forecast by Regions
  • 12.1.1 Global Veterinary Antibiotics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Veterinary Antibiotics Revenue Forecast by Regions 2019-2025
• 12.2 Veterinary Antibiotics Market Forecast by Product
  • 12.2.1 Global Veterinary Antibiotics Sales Forecast by Product 2019-2025
  • 12.2.2 Global Veterinary Antibiotics Revenue Forecast by Product 2019-2025
• 12.3 Veterinary Antibiotics Market Forecast by End User
• 12.4 North America Veterinary Antibiotics Forecast
• 12.5 Europe Veterinary Antibiotics Forecast
• 12.6 Asia Pacific Veterinary Antibiotics Forecast
• 12.7 Central & South America Veterinary Antibiotics Forecast
• 12.8 Middle East and Africa Veterinary Antibiotics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Veterinary Antibiotics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Veterinary Antibiotics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Veterinary Antibiotics market based on company, product type, end user and key regions.

This report studies the global market size of Veterinary Antibiotics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Antibiotics in these regions.
This research report categorizes the global Veterinary Antibiotics market by top players/brands, region, type and end user. This report also studies the global Veterinary Antibiotics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Zoetis animal healthcare
Merck
Merial (Animal Health Division Of Sanofi)
Elanco
Bayer healthcare
Ceva Animal Health, Inc.
Virbac
Boehringer Ingelheim

Market size by Product
Tetracyclines
Penicillins
Macrolides
Sulphonamides
Aminoglycosides
Others
Market size by End User
Farm Animals
Companion Animals

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Veterinary Antibiotics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Veterinary Antibiotics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Veterinary Antibiotics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Veterinary Antibiotics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Veterinary Antibiotics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Veterinary Antibiotics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.